Literature DB >> 26925581

Novel Leptin Receptor Mutations Identified in Two Girls with Severe Obesity Are Associated with Increased Bone Mineral Density.

Sabine E Hannema1, Jan M Wit, Mieke E C A M Houdijk, Arie van Haeringen, Elsa C Bik, Annemieke J M H Verkerk, André G Uitterlinden, Sarina G Kant, Wilma Oostdijk, Egbert Bakker, Henriette A Delemarre-van de Waal, Monique Losekoot.   

Abstract

BACKGROUND: Recessive mutations in the leptin receptor (LEPR) are a rare cause of hyperphagia and severe early-onset obesity. To date, the phenotype has only been described in 25 obese children, some of whom also had altered immune function, hypogonadotropic hypogonadism, reduced growth hormone secretion, hypothalamic hypothyroidism or reduced adult height. We provide a detailed description of the phenotype of 2 affected girls to add to this knowledge.
METHODS: Whole-exome sequencing and targeted sequencing were used to detect the LEPR mutations. RNA analysis was performed to assess the effect of splice-site mutations.
RESULTS: In 2 unrelated girls with severe obesity, three novel LEPR mutations were detected. Longitudinal growth data show normal childhood growth, and in the older girl, a normal adult height despite hypogonadotropic hypogonadism and the lack of an obvious pubertal growth spurt. Bone age is remarkably advanced in the younger (prepubertal) girl, and bone mineral density (BMD) is high in both girls, which might be directly or indirectly related to leptin resistance.
CONCLUSION: The spectrum of clinical features of LEPR deficiency may be expanded with increased BMD. Future observations in LEPR-deficient subjects should help further unravel the role of leptin in human bone biology.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26925581     DOI: 10.1159/000444055

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  14 in total

Review 1.  Influence of body weight on bone mass, architecture and turnover.

Authors:  Urszula T Iwaniec; Russell T Turner
Journal:  J Endocrinol       Date:  2016-06-27       Impact factor: 4.286

Review 2.  Updates on Monogenic Obesity in a Multifactorial Disease.

Authors:  Jared Baxter; Priscila Rodrigues Armijo; Laura Flores; Crystal Krause; Sarah Samreen; Tiffany Tanner
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

Review 3.  The Impact of Fat and Obesity on Bone Microarchitecture and Strength in Children.

Authors:  Joshua N Farr; Paul Dimitri
Journal:  Calcif Tissue Int       Date:  2016-12-24       Impact factor: 4.333

Review 4.  Central hypothyroidism - a neglected thyroid disorder.

Authors:  Paolo Beck-Peccoz; Giulia Rodari; Claudia Giavoli; Andrea Lania
Journal:  Nat Rev Endocrinol       Date:  2017-05-26       Impact factor: 43.330

5.  Young girl with severe early-onset obesity and hyperphagia.

Authors:  Lotte Kleinendorst; Mieke M van Haelst; Erica L T van den Akker
Journal:  BMJ Case Rep       Date:  2017-09-25

Review 6.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14

Review 7.  Leptin Receptor Compound Heterozygosity in Humans and Animal Models.

Authors:  Claudia Berger; Nora Klöting
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

8.  Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse.

Authors:  Brian A Droz; Bria L Sneed; Charles V Jackson; Karen M Zimmerman; M Dodson Michael; Paul J Emmerson; Tamer Coskun; Richard G Peterson
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

9.  Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman; Jorge Alsina-Fernandez; M Dodson Michael; Paul J Emmerson; Tamer Coskun
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

10.  Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

Authors:  Shu-Mei Chen; Yi-Jen Peng; Chih-Chien Wang; Sui-Lung Su; Donald M Salter; Herng-Sheng Lee
Journal:  Int J Med Sci       Date:  2018-03-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.